Odyssey Health (ODYY) EBIT Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.06% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 20.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 74.18% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 90.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -18.12% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 46.60% |
| 10 | Odyssey Health | - | - | - | -16.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -16.19% |
| Oct 31, 2025 | 47.67% |
| Jul 31, 2025 | -165.57% |
| Apr 30, 2025 | 65.34% |
| Jan 31, 2025 | 86.47% |
| Oct 31, 2024 | -66.87% |
| Jul 31, 2024 | 136.24% |
| Apr 30, 2024 | 65.98% |
| Jan 31, 2024 | 22.14% |
| Oct 31, 2023 | 83.29% |
| Jul 31, 2023 | 64.29% |
| Apr 30, 2023 | 61.81% |
| Jan 31, 2023 | 24.77% |
| Oct 31, 2022 | -45.36% |
| Jul 31, 2022 | 29.63% |
| Apr 30, 2022 | 76.30% |
| Jan 31, 2022 | -211.77% |
| Oct 31, 2021 | -172.12% |
| Jul 31, 2021 | -125.45% |
| Apr 30, 2021 | -1,293.89% |
| Jan 31, 2021 | -26.82% |
| Oct 31, 2020 | 60.29% |
| Jul 31, 2020 | 95.06% |
| Apr 30, 2020 | -1,820.08% |
| Jan 31, 2020 | -456.75% |
| Oct 31, 2019 | -2,424.08% |
| Jul 31, 2019 | -28,500.69% |
| Apr 30, 2019 | 21.27% |
| Jan 31, 2019 | 61.27% |
| Oct 31, 2018 | -5.87% |
| Jul 31, 2018 | -53.62% |
| Apr 30, 2018 | 20.72% |
| Jan 31, 2018 | -790.39% |
| Oct 31, 2017 | -211.13% |
| Jul 31, 2017 | -71.60% |
| Apr 30, 2017 | -2,217.48% |
| Jan 31, 2017 | -76.64% |
| Oct 31, 2016 | 35.55% |
| Jul 31, 2016 | -29.55% |
| Apr 30, 2016 | 92.63% |
| Jan 31, 2016 | 70.22% |
| Oct 31, 2015 | 38.42% |